Liver-specific LINC01146, a Promising Prognostic Indicator, Inhibits the Malignant Phenotype of Hepatocellular Carcinoma Cells Both in Vitro and in Vivo

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2022 Feb 1

PMID 35101062

Authors

Xiaoyun Ma

Meile Mo

Chao Tan

Jennifer Hui Juan Tan

Huishen Huang

Bihu Liu

Dongping Huang

Shun Liu

Xiaoyun Zeng

Xiaoqiang Qiu

Affiliations

Soon will be listed here.

Abstract

Background: Long non-coding RNAs (lncRNAs) are involved in the development of hepatocellular carcinoma (HCC). We aimed to investigate the function of LINC01146 in HCC.

Methods: The expression of LINC01146 in HCC tissues was explored via The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases and was verified using quantitative real-time polymerase chain reaction (qRT-PCR) in our HCC cohort. Kaplan-Meier analysis was used to assess the relationship between LINC01146 and the prognosis of HCC patients. Cell Counting Kit 8, colony formation assays, Transwell assays, flow cytometric assays, and tumour formation models in nude mice were conducted to reveal the effects of LINC01146 on HCC cells both in vitro and in vivo. Bioinformatic methods were used to explore the possible potential pathways of LINC01146 in HCC.

Results: LINC01146 was significantly decreased in HCC tissues compared with adjacent normal tissues and was found to be related to the clinical presentations of malignancy and the poor prognosis of HCC patients. Overexpression of LINC01146 inhibited the proliferation, migration, and invasion of HCC cells in vitro, while promoting their apoptosis. In contrast, downregulation of LINC01146 exerted the opposite effects on HCC cells in vitro. In addition, overexpression of LINC01146 significantly inhibited tumour growth, while downregulation of LINC01146 promoted tumour growth in vivo. Furthermore, the coexpressed genes of LINC01146 were mainly involved in the "metabolic pathway" and "complement and coagulation cascade pathway".

Conclusion: LINC01146 expression was found to be decreased in HCC tissues and associated with the prognosis of HCC patients. It may serve as a cancer suppressor and prognostic biomarker in HCC.

Citing Articles

Evidence for a Role of the Long Non-Coding RNA ITGB2-AS1 in Eosinophil Differentiation and Functions.

Fettrelet T, Hosseini A, Wyss J, Boros-Majewska J, Stojkov D, Yousefi S Cells. 2024; 13(23).

PMID: 39682685 PMC: 11640120. DOI: 10.3390/cells13231936.

High-Throughput Single-Nucleus RNA Profiling of Minimal Puncture FFPE Samples Reveals Spatiotemporal Heterogeneity of Cancer.

Jiang W, Zhang X, Xu Z, Cheng Q, Li X, Zhu Y Adv Sci (Weinh). 2024; 12(4):e2410713.

PMID: 39630113 PMC: 11789576. DOI: 10.1002/advs.202410713.

Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons.

Goyal H, Parwani S, Kaur J Cell Death Discov. 2024; 10(1):451.

PMID: 39448589 PMC: 11502918. DOI: 10.1038/s41420-024-02200-2.

Kolpakov S, Yashkin A, Ukraintseva S, Yashin A, Akushevich I J Racial Ethn Health Disparities. 2024; .

PMID: 38273182 PMC: 11269527. DOI: 10.1007/s40615-024-01907-3.

Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.

Mo M, Ma X, Luo Y, Tan C, Liu B, Tang P BMC Cancer. 2022; 22(1):1098.

PMID: 36289466 PMC: 9609286. DOI: 10.1186/s12885-022-10186-2.

References

Okano J, Nagahara T, Matsumoto K, Murawaki Y . Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin Pharmacol Toxicol. 2008; 102(6):543-51. DOI: 10.1111/j.1742-7843.2008.00231.x. View

Liao Y, Wang J, Jaehnig E, Shi Z, Zhang B . WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019; 47(W1):W199-W205. PMC: 6602449. DOI: 10.1093/nar/gkz401. View

Kim S, Kudo M, Hino O, Han K, Chung Y, Lee H . Epidemiology of hepatocellular carcinoma in Japan and Korea. A review. Oncology. 2008; 75 Suppl 1:13-6. DOI: 10.1159/000173419. View

Barrett T, Wilhite S, Ledoux P, Evangelista C, Kim I, Tomashevsky M . NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2012; 41(Database issue):D991-5. PMC: 3531084. DOI: 10.1093/nar/gks1193. View

Du M, Chen L, Zhao J, Tian F, Zeng H, Tan Y . Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma. BMC Cancer. 2014; 14:38. PMC: 3922738. DOI: 10.1186/1471-2407-14-38. View

Tomczak K, Czerwinska P, Wiznerowicz M . The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015; 19(1A):A68-77. PMC: 4322527. DOI: 10.5114/wo.2014.47136. View

He J, Zuo Q, Hu B, Jin H, Wang C, Cheng Z . A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Lett. 2019; 450:98-109. DOI: 10.1016/j.canlet.2019.02.033. View

Zhong J, Xiang X, Wang Y, Liu X, Qi L, Luo C . The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression. J Cell Physiol. 2019; 235(2):1090-1102. DOI: 10.1002/jcp.29023. View

Zhang L, Wang Y, Sun J, Ma H, Guo C . LINC00205 promotes proliferation, migration and invasion of HCC cells by targeting miR-122-5p. Pathol Res Pract. 2019; 215(9):152515. DOI: 10.1016/j.prp.2019.152515. View

10.

Guo X, Wang Y . LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway. Cancer Med. 2020; 9(14):5235-5246. PMC: 7367632. DOI: 10.1002/cam4.3046. View

11.

Tsai W, Hsu P, Lai T, Chau G, Lin C, Chen C . MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009; 49(5):1571-82. DOI: 10.1002/hep.22806. View

12.

Song X, Ren X, Xu X, Ruan X, Wang Y, Yao T . LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma. Technol Cancer Res Treat. 2020; 19:1533033820957023. PMC: 7491227. DOI: 10.1177/1533033820957023. View

13.

Huang R, Wang X, Zhang W, Zhangyuan G, Jin K, Yu W . Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma. Cell Physiol Biochem. 2016; 40(3-4):707-715. DOI: 10.1159/000452582. View

14.

Wang Y, Jing W, Ma W, Liang C, Chai H, Tu J . Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma. Cancer Biomark. 2018; 22(2):227-236. DOI: 10.3233/CBM-170781. View

15.

Guo Y, Wang L, Ma R, Mu Q, Yu N, Zhang Y . JiangTang XiaoKe granule attenuates cathepsin K expression and improves IGF-1 expression in the bone of high fat diet induced KK-Ay diabetic mice. Life Sci. 2016; 148:24-30. DOI: 10.1016/j.lfs.2016.02.056. View

16.

Guo F, Zhu X, Zhao Q, Huang Q . miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R. Int J Mol Med. 2020; 46(3):989-1002. PMC: 7388824. DOI: 10.3892/ijmm.2020.4666. View

17.

Fagerberg L, Hallstrom B, Oksvold P, Kampf C, Djureinovic D, Odeberg J . Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2013; 13(2):397-406. PMC: 3916642. DOI: 10.1074/mcp.M113.035600. View

18.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

19.

Quagliata L, Matter M, Piscuoglio S, Arabi L, Ruiz C, Procino A . Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2013; 59(3):911-23. PMC: 3943759. DOI: 10.1002/hep.26740. View

20.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View